Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Turkey tail mushroom (Trametes versicolor) has a long history of use in traditional Chinese medicine, but its application for hepatitis specifically is supported by emerging, though limited, scientific evidence. Polysaccharopeptides (PSP) and polysaccharide-K (PSK) are the main bioactive compounds isolated from turkey tail mushrooms. These compounds exhibit immunomodulatory and hepatoprotective properties in preclinical studies. Animal models have demonstrated that extracts from turkey tail can reduce liver inflammation and damage induced by hepatitis viruses or toxins, likely by modulating immune responses and reducing oxidative stress.

Some small human trials and case series have explored turkey tail in the context of chronic hepatitis B or C, suggesting potential benefits such as reduced liver enzymes (ALT, AST) and improved immune markers. However, these studies are often limited by small sample sizes, lack of control groups, or methodological weaknesses. A few studies from China have used PSK or PSP as adjuncts to standard antiviral therapy, with mixed results.

To date, there are no large-scale, high-quality clinical trials confirming efficacy for hepatitis in humans, and turkey tail is not part of conventional hepatitis treatment guidelines. While historical use and early research are promising, more rigorous research is needed to validate its role in managing hepatitis. People considering turkey tail for hepatitis should do so under medical supervision, especially due to possible interactions with standard medications.

More about Turkey tail mushroom
More about Hepatitis

Other ingredients used for Hepatitis

Other health conditions supported by Turkey tail mushroom

Products containing Turkey tail mushroom

Pure Encapsulations Coriolus Extract
Metagenics ImmuCore
Metagenics Mycotaki®
Pure Encapsulations PureDefense Collagen with Bone Broth